Experienced business development executive to accelerate Cosette’s growth trajectory

Bridgewater, NJ. December 14, 2023. Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced the appointment of Ted Smolenski as Vice President, Portfolio and Business Development, bolstering its product portfolio and business development team.

“We are excited to have Ted join our business development team as we continue to pursue further inorganic growth in our branded and generics portfolios.  As we look to build upon our recent transactions and global partnerships, Ted will be instrumental in strategic product selection for our product portfolio, product licensing and acquisitions,” said Apurva Saraf, President and CEO, Cosette Pharmaceuticals.

“I am excited to join the Cosette team during this period of rapid growth. I look forward to building upon Cosette’s deep internal R&D and external BD execution experience and track record,” said Ted Smolenski, Vice President, Product Portfolio and Business Development, Cosette Pharmaceuticals.  Ted brings to Cosette over 23 years of experience in the pharmaceuticals industry. Most recently, Ted was at Slayback Pharmaceuticals where he led Slayback’s business development efforts by identifying partnership opportunities and driving business deals to successful close.  Ted was also part of Slayback’s core deal team responsible for the company’s recent sale to Azurity. Previously, Mr. Smolenski was Head of Business Development at Rhodes Pharmaceuticals, where he played a lead role in business development and alliance management.  Prior to Rhodes, Mr. Smolenski was Putney’s Vice President of Business Development and Portfolio where he led Putney’s portfolio process and closed business deals to drive Putney’s growth.  Earlier in his career, Mr. Smolenski was Senior Director of Portfolio Management and Strategy at Impax Laboratories where his team had responsibility for portfolio strategy, alliance management, API sourcing, and PIV settlement negotiation. Mr. Smolenski holds a Bachelor Degree in Civil Engineering and a Master of Business Administration from the University of Delaware.

About Cosette Pharmaceuticals, Inc.:

Cosette Pharmaceuticals, Inc. (“Cosette”) is a US-based, fully integrated pharmaceutical company with capabilities in product development, manufacturing, and commercial operations. Cosette has a fast-growing portfolio of branded pharmaceuticals consisting of products in women’s health, cardiology and dermatology. Cosette has a long history in quality manufacturing of complex dosage forms including topical creams, ointments, oral liquids/solutions and suppositories. Cosette has corporate and manufacturing facilities in New Jersey and North Carolina and is supported by 300+ dedicated employees across all functional areas. Cosette is backed by Avista Capital Partners, a healthcare focused private equity firm. www.cosettepharma.com


Serge Ilin-Schneider: bd@cosettepharma.com

Kian Kazemi: sales@cosettepharma.com